Neuropharmacology: Oxime antidotes for organophosphate pesticide and nerve agent poisoning

Pub Date : 2020-12-30 DOI:10.18054/PB.V121-122I1-2.10623
Tamara Zorbaz, Z. Kovarik
{"title":"Neuropharmacology: Oxime antidotes for organophosphate pesticide and nerve agent poisoning","authors":"Tamara Zorbaz, Z. Kovarik","doi":"10.18054/PB.V121-122I1-2.10623","DOIUrl":null,"url":null,"abstract":"Organophosphate (OP) compounds remain a great threat for humans because they are used as pesticides or misused as chemical warfare nerve agents. Their mechanism of toxicity involves the irreversible inhibition of the acetylcholinesterase (AChE) enzyme important in the control of cholinergic neurotransmission at the periphery and in the brain. An available pharmacological treatment are oxime compounds, that are reactivators of OP-inhibited AChE. However, oximes are not equally effective for every possible OP and they cross the blood-brain barrier (BBB) poorly. Novel oximes are being designed and synthesized at a high rate and scale and their pharmacological efficiency is being addressed mostly with the in vitro reactivation assay. Nevertheless, only few newly synthesized oximes have shown comparable or better pharmacological properties than the ones developed more than 65 years ago beacuse oxime potential to act as efficient antidote in vivo depends on its pharmacokinetic and neuropharmacokinetics profile. This paper provides an overview of all the important aspects that should be accounted for in the search for a centrally active oxime. Furthermore, it lists the most important BBB oxime delivery strategies employed until now, and the available pharmacokinetic data on old and new oximes. NEUROTOXIC ORGANOPHOSPHATES N disorders include different conditions categorized as neurodegenerative, neuroinflammatory, neuropsychiatric, and other diseases, and as such represent one of the major global public health challenges that affect hundreds of millions of peoples worldwide (1). Conditions that originate at the level of the central nervous system (CNS) are difficult to treat both pharmacologically and surgically due to the specific anatomy and physiology of the nervous system. In addition, the nervous system is the target of many toxic compounds such as highly lethal synthetic organophosphorus compounds (OPs) derived from phosphorous, phosphonic, or phosphonic acid. They were primarily developed and used as pesticides; however, they turned out to be toxic for different species, including humans; therefore, many OP pesticides have been banned, e.g., parathion, dichlorvos (2, 3). The incidence of intentional/unintentional OP pesticide poisoning is about 3 million cases per year, while lethal outcomes of poisoning (about 200 000 cases) have mostly been recorded in developing or under-developed countries due to a lack of strict pesticide use regulation and proper medical care (4, 5). In addition, OPs are mostly colourless and odourless TAMARA ZORBAZ*","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.18054/PB.V121-122I1-2.10623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Organophosphate (OP) compounds remain a great threat for humans because they are used as pesticides or misused as chemical warfare nerve agents. Their mechanism of toxicity involves the irreversible inhibition of the acetylcholinesterase (AChE) enzyme important in the control of cholinergic neurotransmission at the periphery and in the brain. An available pharmacological treatment are oxime compounds, that are reactivators of OP-inhibited AChE. However, oximes are not equally effective for every possible OP and they cross the blood-brain barrier (BBB) poorly. Novel oximes are being designed and synthesized at a high rate and scale and their pharmacological efficiency is being addressed mostly with the in vitro reactivation assay. Nevertheless, only few newly synthesized oximes have shown comparable or better pharmacological properties than the ones developed more than 65 years ago beacuse oxime potential to act as efficient antidote in vivo depends on its pharmacokinetic and neuropharmacokinetics profile. This paper provides an overview of all the important aspects that should be accounted for in the search for a centrally active oxime. Furthermore, it lists the most important BBB oxime delivery strategies employed until now, and the available pharmacokinetic data on old and new oximes. NEUROTOXIC ORGANOPHOSPHATES N disorders include different conditions categorized as neurodegenerative, neuroinflammatory, neuropsychiatric, and other diseases, and as such represent one of the major global public health challenges that affect hundreds of millions of peoples worldwide (1). Conditions that originate at the level of the central nervous system (CNS) are difficult to treat both pharmacologically and surgically due to the specific anatomy and physiology of the nervous system. In addition, the nervous system is the target of many toxic compounds such as highly lethal synthetic organophosphorus compounds (OPs) derived from phosphorous, phosphonic, or phosphonic acid. They were primarily developed and used as pesticides; however, they turned out to be toxic for different species, including humans; therefore, many OP pesticides have been banned, e.g., parathion, dichlorvos (2, 3). The incidence of intentional/unintentional OP pesticide poisoning is about 3 million cases per year, while lethal outcomes of poisoning (about 200 000 cases) have mostly been recorded in developing or under-developed countries due to a lack of strict pesticide use regulation and proper medical care (4, 5). In addition, OPs are mostly colourless and odourless TAMARA ZORBAZ*
分享
查看原文
神经药理学:有机磷农药和神经毒剂中毒的肟解毒剂
由于有机磷化合物被用作杀虫剂或被误用为化学战神经毒剂,对人类构成了巨大威胁。它们的毒性机制涉及对乙酰胆碱酯酶(AChE)的不可逆抑制,AChE在控制外周和大脑的胆碱能神经传递中很重要。一种可用的药物治疗是肟类化合物,它是op抑制乙酰胆碱酯酶的再激活剂。然而,肟并不是对所有可能的OP都同样有效,而且它们通过血脑屏障(BBB)的效果也很差。新型肟类化合物正以较高的速度和规模被设计和合成,其药理作用主要是通过体外再激活试验来研究的。然而,只有少数新合成的肟显示出与65年前开发的肟相当或更好的药理学特性,因为肟在体内作为有效解毒剂的潜力取决于其药代动力学和神经药代动力学特征。本文概述了在寻找集中活性肟时应考虑的所有重要方面。此外,它列出了迄今为止采用的最重要的血脑屏障肟递送策略,以及现有的新旧肟的药代动力学数据。神经毒性有机磷酸盐N疾病包括不同的疾病,如神经退行性疾病、神经炎症、神经精神疾病和其他疾病,因此代表了影响全世界数亿人的主要全球公共卫生挑战之一(1)。由于神经系统的特定解剖和生理学,起源于中枢神经系统(CNS)水平的疾病难以通过药物和手术治疗。此外,神经系统是许多有毒化合物的目标,如来自磷、膦或膦酸的高致死合成有机磷化合物(OPs)。它们最初是作为杀虫剂开发和使用的;然而,它们对包括人类在内的不同物种都是有毒的;因此,许多有机磷农药已被禁止,例如对硫磷、敌敌畏(2,3)。有意/无意有机磷农药中毒的发生率每年约为300万例,而由于缺乏严格的农药使用监管和适当的医疗护理,中毒的致命后果(约20万例)大多发生在发展中国家或欠发达国家(4,5)。此外,有机磷农药大多是无色无味的TAMARA ZORBAZ*
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信